Pharmaceutical manufacturers of Inosine

Established in Darmstadt, Germany in 1668 by Friedrich Jacob Merck, Merck KGaA stands as the oldest pharmaceutical and chemical corporation globally. It is renowned for its pioneering and high-quality advanced products in the fields of healthcare, life science, and performance materials. Internationally, the company is recognized as Merck, while operating as EMD Serono in the Biopharma sector, as MilliporeSigma in the Life Science sector, and as EMD Performance Materials in the materials sector in the United States and Canada.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

ICE Pharma's primary focus is on the production of active pharmaceutical ingredients, with Ursodeoxycholic Acid (UDCA) being the key component, utilized in the treatment of liver conditions and gallstones. The company specializes in creating a variety of bile acid derivatives that serve as excipients, nutraceutical ingredients, cell culture media, and intermediates. Additionally, ICE Pharma offers contract manufacturing services for both liquid and solid finished dosage forms, catering to branded and generic products. Advent International, a leading global private equity investor, has owned ICE Pharma since October 2019.